Provider Brochure: "Providing Optimal Care for Your MSM Patients"
Medical providers have a critical role to play in improving the health outcomes of Black and Latino men who have sex with men (BLMSM). Studies reinforce the significance of clinicians offering vaccine and recommending diagnostic STD testing. Click above to view a brochure to assist health care providers in improving the health care they provide to their MSM patients.
Straight Talk Guide: Counseling Patients about External Gential and Perianal Warts (EGW)
Click above to view an easy to use guide for healthcare providers about external genital warts (EGWs), a commonly occurring outcome of HPV infection. The guide focuses on treatment options for EGWs and empowers healthcare providers to engage in a discussion with their clients about EGWs.
Shifting to Third-Party Billing Practices for Public Health STD Services: Policy Context and Cases Studies
The National Coalition of STD Directors (NCSD) has collaborated with key partners to develop a resource to support the sustained delivery of STD services in the face of a changing funding and policy landscape. This guide seeks to meet the needs of a range of providers, serving not as a technical manual, but rather an introduction to what providers need to consider as they approach the decisions surrounding third-party billing.
Rapid Syphilis Test Pamphlet
Between 1990 and 2000, rates of primary & secondary (P&S) syphilis in the U.S. declined by nearly 90% and in 2000, reached the lowest level since reporting began in 1941. However, since 2001, rates have again begun to climb, calling on all of us to help reverse this trend. Syphilis is easily treated in most cases, but screening and testing is the initial front line to ensuring we drive incidence lower.
This brief guide is designed as a primer to educate clinicians and other healthcare providers about the need for increased targeted screening and testing among high risk populations and to discuss the implications of the first ever rapid syphilis test (RST) approved by the Food and Drug Administration for use in the United States.